Radiant Pharma Form I Annexure

Home , Chittoor district, Gajulamandyam, Narayanavanam, Renigunta, Renigunta mandal

RADIANT PHARMA SY. NO. 62A, GAJULAMANDYAM IDA, RENIGUNTA MANDAL, CHITTOR DISTRICT, ANDHRA PRADESH

FORM I

Project No. 0519-16-01 May 2019

STUDIES AND DOCUMENTATION BY Radiant Pharma TEAM Labs and Consultants Door No. 19-3-29/D1, Kennedy Nagar, B-115-117 & 509, Annapurna Block, Tiruchanoor Road, Tirupati, Chittoor, Aditya Enclave, Ameerpet, Andhra Pradesh – 517 502 Hyderabad-500 038. Phone: +91 98663 01899 Phone: 040-23748 555/23748616, E-mail: [email protected] Telefax: 040-23748666

SUBMITTED TO STATE LEVEL ENVIRONMENT IMPACT ASSESSMENT AUTHORITY, ANDHRA PRADESH, GOVERNMENT OF INDIA Radiant Pharma

APPENDIX – I (See Paragraph – 6) FORM I

I) Basic Information S.No. Item Details 1 Name of the Project/s Radiant Pharma 2 5 f – B category - Synthetic Organic Chemicals S. No in the Schedule (Bulk Drug and Intermediates) 3 Propose d capacity/area/le ng th/tonnage to be Production Capacity: 2000 Kg/day handled/command area/lease area/number of Total Lease Site Area: 1.55 acres wells to be drilled Project Cost: 4.2 Crores Propose to manufacture 2 products out of 4 products on campaign basis. 4 New/Expa ns ion/ Modernization New 5 Existing Capacity/Area etc. Not Applicable 6 Category of Project i.e. 'A' or 'B' “B” 7 Does it attract the general condition? If yes, No please specify 8 Does it attract the Specific condition? If yes, No please specify. 9 Lo ca tion Plot/Survey/Khasra No. Sy. No. 62 A, APIIC , Industrial Park, Gajulamandyam IDA Village Gajulamandyam Village Tehsil Renigunta Mandal District Chittoor District State Andhra Pradesh 10 Nearest railway station/airport al ong with Renigunta Railway Station – North – 4. 7 Km distance in kms. Renigunta Airport – North – 4.3 Km 11 Nearest Town, City, District Headquarters Renigunta – North – 4. 2 km along with distance in kms. 12 Village Panchayats, Zilla Parishad, Municipal Gajulamandyam Panchayath Corporation, Local body (complete postal address with telephone nos. to be given) 13 Name of the Applicant C. Shankar Giri B abu 14 Registered Address Sy. No. 62 A, Gajulamandyam IDA, Renigunta Mandal, Chittoor District, Andhra Pradesh. 15 Address f or Corres po ndence: Name C. Shankar Giri B abu Designation(Owner/Partner/CEO) Managing Partner Address Door No. 19 -3-29/D1 , Kennedy Nagar , Tiruchanoor Road, Tirupati, Chittoor Andhra Pradesh Pin Code 517 502 E-mail radiant pha rma1974 @gmail.com Telephone Number +91 -98663 01899 Fax No.

Form I Page 1

Radiant Pharma

16 Details of alternative Sites examined, if any. -NA - Location of these sites should be shown on a topo sheet. 17 Int erlinked Projects -NA - 18 Whether separat e applica ti on of interlinked No project has been submitted? 19 If yes, date of submission 20 If no, reason 21 Whether the proposal involves -NA - approval/clearance under: if yes, details of the same and their status to be given. (a) The Forest (Conservation) Act, 1980? (b) The Wildlife (Protection) Act, 1972? (c) The C.R.Z Notification, 1991? 22 Whether there is any Gove rnment No Order/Policy relevant/relating to the site? 23 Forest land involved (hectares) No 24 Whether there is any location pending against No the project and /or land in which the project is propose to be set up? (a) Name of the Court (b) Case No (c) Orders/directions of the Court, if any and its relevance with the proposed project.

Form I Page 2

Radiant Pharma

(II) Activity

1. Construction, operation or decommissioning of the Project involving actions, which will cause physical changes in the locality (topography, land use, changes in water bodies, etc.) S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate quantit ies /rates, wherever possible) with source of information data 1.1 Permanent or temporary change in land NO The land on lease area used for the pr oposed use, land cover or topography including plant is 1.55 acres. increase in intensity of land use (with respect to local land use plan) 1.2 Clearance of existing land, vegetation NO The proposed land area is located in 62 A, APIIC, and buildings? Industrial Park, Gajulamandyam IDA 1.3 Creation of new land uses? NO 1.4 Pre -construction investigati ons e. g. bo re YE S Soil test done and soil load bearing capacity houses, soil testing? established. 1.5 Construction works? YES Construction activity involves creation of new production blocks, utilities like Boilers, Chilling Plant etc ; 1.6 Demolition works? NO 1.7 Temporary sites used f or construction NO Construction labor from local villages shall be works or housing of construction employed. workers? 1.8 Above ground buildings, structures or YES Storage facilities sha ll be constructed. No major earthworks including linear structures, cut and fill or excavation is anticipated. cut and fill or excavations 1.9 Underground works including mining or NO tunneling? 1.10 Reclamation works? NO 1.11 Dredging? NO 1.12 Of fshore structures? NO 1.13 Pr oduct ion and manufacturing YES Enclosed in Annexure – I processes? 1.14 Facilities for storage of goods or NO Raw materials and solvents shall be stored with in materials? factory premises. Materials in bags and drums will be stored in properly designed warehouse with adequate safe guards. Bulk quantities of raw materials will be stored in Bulk Storage tanks in the tank farms with retention dykes. 1.15 Facilities for treatment or disposal of YES Effluent is treated w ith in the plant premises. solid waste or liquid effluents? Organic waste is sent to cement plants for co- incineration. Solid waste generated from Multiple Effect evaporators sent to TSDF. Details of waste treatment facilities presented in Annexure II.

Form I Page 3

Radiant Pharma

1.16 Facilities for long term housin g of NO Loc al people shall be employed. operational workers? 1.17 New road, rail or sea traffic during YES Construction materials shall be transported to the construction or operation? site. The traffic density of the existing connecting road is negligible . 1.18 New road, rail, air waterborne or other NO transport infrastructure including new or altered routes and stations, ports, airports etc? 1.19 Closure or diversion of existing transport NO routes or infrastructure leading to changes in traffic movements? 1.20 New or divert ed transmission lines or NO pipelines? 1.21 Impoundment, damming, culverting, NO realignment or other changes to the hydrology of watercourses or aquifers? 1.22 Stream crossings? NO 1.2 3 Abstraction or transfer s of w ater form YES Total water required shall be 58.4 KLD out of ground or surface waters? which 33.4 KLD shall be drawn from bore well and the balance shall be recycled water 1.24 Changes in water bodies or the land NO surface affecting drainage or run-off? 1.25 Transport of personnel or materials for YES The construction material shall be drawn from construction, operation or local sources within 10 – 15 km. There is no decommissioning? transport of personnel, as the construction workers shall be drawn from local villages. 1.26 Long -ter m dismantling or NO decommissioning or restoration works? 1.27 Ongoing activity during decommissioning NO which could have an impact on the environment? 1.28 Influx of people to an area in e ither YES The proposed project sha ll increase the temporarily or permanently? employment potential and hence may lead to migration to surrounding villages. 1.29 Introduction of alien species? NO 1.30 Loss of native species or genetic NO There are no major losses of tree/s hrub species. diversity? 1.31 Any other ac tions? NO

Form I Page 4

Radiant Pharma

2. Use of Natural resources for construction or operation of the Project (such as land, water, materials or energy, especially any resources which are non-renewable or in short supply): S.No. Information/ checkl ist c onfirmation Yes/No Details thereof (with approximate quantities /rates, wherever possible) with source of information data 2.1 Land especially undeveloped or NO Land area 1.55 acres agricultural land (ha) Located at Sy. No. 62 A, Gajulamandyam IDA, Renigunta Mandal, Chittoor District, Andhra Pradesh. 2.2 Water (expected source & competing YES Total water required shall be 58.4 KLD out of users) unit: KLD which 33.4 KLD shall be drawn from bore well and the balance shall be recycled water. (Water Balance Enclosed in Annexure III) 2.3 Minerals (MT) NA 2.4 Construction material – stone, YES Shall be sourced from the local villages. aggregates, sand / soil (expected source – MT) 2.5 Fore sts and timber (source – MT) NO 2.6 Energy including electricity and fuels YES The energy source is Coal Fired Boiler of 2 TPH (source, competing users) Unit: fuel capacity to meet the steam requirement. The (MT), energy (MW) required quantity of fuel for proposed 2 TPH boiler shall be 9.87 TPD 2.7 Any oth er natural r esources (use NA appropriate standard units)

Form I Page 5

Radiant Pharma

3. Use, storage, transport, handling or production of substances or materials, which could be harmful to human health or the environment or raise concerns about actual or perceived risks to human health. S.No. Information/Checklist confirm ation Yes/No Details thereof (with approximate quantities/rates, wherever possible) with source of information data 3.1 Use of substances or materials, which are YES Solvents shall be used as reaction media. MSIHC hazardous (as per MSIHC rules) to human rules shall be followed during storage, heal th or the environment (flora, fauna, transportation and handling of raw materials and and water s upplies) hazardous chemicals. 3.2 Changes in occurrence of diseas e or NO affect disease vectors (e.g. insect or water borne diseases). 3.3 Affect the welfare of people e.g. by YES Shall increase the employment potential for locals changing living conditions? and affect the living conditions for betterment.

3.4 Vulner able groups of people who could NO No sensitive receptors are present in the be affected by th e project e.g. hospital immediate vicinity of the site. The project shall patients, children, the elderly etc., not have any significant impact on vulnerable groups of people. 3.5 Any other causes NO

4. Production of solid wastes during construction or operation or decommissioning (MT/month) S.N o. Information/Checklist confirmation Yes/No Details thereof (with approximate quantities/rates, wherever possible) with source of information data 4.1 Spoil, over burden or mine wastes NO 4.2 Municipal waste (domestic and or NO Wastes from canteen, other commercial wastes commercial wastes) like paper, empty containers etc. The canteen wastes and commercial wastes shall be in the range of 1 kg/day 4.3 Ha zardous wastes (as per Hazardous YES The quantity of hazardous waste s generated Waste Management Rules) during construction contains waste oils and batteries from DG set.

The quantity of hazardous waste generated during operation contain salts from evaporators, distillate, process residue, and solvent residues, sludge and filtration media etc. enclosed in Annexure – IV 4.4 Other industrial process wastes YES Enclosed at Annexure IV 4.5 Surplus product NO 4.6 Sewage sludge or other sludge from YES Sludge from Effluent treatment System shall be efflue nt treatment sent to TSDF.

Form I Page 6

Radiant Pharma

4.7 Constructio n or demolition wastes NO Construction activity involves creation of new production blocks, utilities like boilers, Chilling Plant etc., 4.8 Redundant machine ry or equipment NO 4.9 Contaminated soils or other materials NO Structures of all waste treat ment facilities are made of concrete and also above ground to eliminate the possibility of any contamination due to seepage and for ease of maintenance. 4.10 Ag ricultural wastes NO 4.11 Other solid wastes NO Enclosed at Annexure IV

5. Release of pollutants or any hazardous, toxic or noxious substances to air (Kg/hr) S.No. Information/Checklist confirmation Yes/No Details ther eof (with approximate quantities/rates, wherever possible) with source of information data 5.1 Emissions from combustion of foss il fuels YES Coal Shall be used as fuel. Quantity of fuel and from stationary or mobile sources emissions details are enclosed in Annexure V

5.2 Emissions from production processes YES Enclosed in Annexure - VI 5.3 Emissions from materials handling NO Material transfer takes place in closed pipeline inclu ding storage or transport systems using pumps with mechanical seals. 5.4 Emissions from construction activit ies YES Dust may rise during transport of material and including plant and equipment construction activity. The dust emissions shall be mitigated by water spraying on the roads within the premises. 5.5 Dust or odors fro m handling of materials NO including construction materials, sewage and waste 5.6 Emissions from incineration of waste NO 5. 7 Emissions from burning of waste in open NO air (e.g. slash materials, construction debris) 5.8 Emissions from a ny other sou rces NO

Form I Page 7

Radiant Pharma

6. Generation of Noise and Vibration, and Emissions of Light and Heat: S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate quantities/rates, wherever possible) with source of information data with source of information data 6.1 From operation of eq uipment e.g. YES Material transport and construction equip ment shall be engines, ventilation plant, crushers source of noise, while transfer pumps, vacuum systems, DG sets are the sources of noise during operation. 6.2 From industrial or similar process es YES From DG sets, and controlled by providing Acoustic Enclosures. 6.3 From construction or demolition YES Noise during construction shall be due to construction equipment and emergency DG sets. 6.4 Fro m blasting o r piling NO

6.5 From constructio n or operational NO The increased traffic shall not have any significant traffic impact. 6.6 From lighting or cooling systems NO 6.7 From any other sources NO

7.Risks of contamination of land or water from releases of pollutants into the ground or into sewers, surface waters, groundwater, coastal waters or the sea: S.No. Informatio n/Checklist confirmation Yes/No Details thereof (with approximate quantities/rates, wherever possible) with source of information data 7.1 From handling, stora ge, use or NO All the hazardous materials will be stored in Tan ks/ MS spillage of hazardous materials drums, in a covered shed and no contamination of soil is expected 7.2 From discharge of sewage or other NO All the wastes from domestic operations are sent to eff luents to water or the land septic tank. (expected mode an d place of discharge)

7.3 By deposition of pollutants emitted NO Air Pollutants generated are let out into atmosphere to air into the land or into water after meeting the prescribed standards. 7.4 From any other sources NO 7.5 Is there a risk of long term build up NO of pollutan ts in environment from these sources?

Form I Page 8

Radiant Pharma

8.Risk of accidents during construction or operation of the Project, which could affect human health or the environment S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate quantities/rates, wherever possible) with source of information data

8.1 From explosions, spillages, fires etc from YES All Inbuilt Safety precautions will be storage, handling, use or production of adopted and there will not be any hazardous substances damage to environment or human health 8.2 From any other causes NA 8.3 Could the project be affected by natural NO disasters causing environmental damage (e.g? Floods, earthquakes, landslides, cloudburst etc)?

9.Factors which should be considered (such as consequential development) which could lead to environmental effects or the potential for cumulative impacts with other existing or planned activities in the locality S. No. Information/Checklist confirmation Yes/No Details thereof (with approximate quantities/rates, wherever possible) with source of information data 9.1 Lead to development of supporting . YES The project shall enhance the socio facilities, ancillary development or development economic status of the area by stimulated by the project which could have impact increasing the demand for housing, on the environment e.g.: improving the employment. There are • Supporting infrastructure (roads, power supply, no major support industries required waste or waste water treatment, etc.) for this plant. • housing development • extractive industries • supply industries • other 9.2 Lead to a fter -use of the site, which could haven NO impact on the environment 9.3 Set a precedent for later developments NO 9.4 Have cumulative e ffects due to proximity to other NO The baseline environmental status of existing or planned projects with similar effects the surrounding areas is within the prescribed limits as observed from the Secondary data.

Form I Page 9

Radiant Pharma

(III) Environmental Sensitivity S.No. Areas Name/ Aerial distance (within 15 km.) Proposed Identity project location boundary 1 Areas protected un der internat ional conventions, NA national or local legislation for their ecological, landscape, cultural or other related value 2 Ar eas which are important or sensitive for YES Narayanavanam RF – SE – 6.3 Km, ecological reasons - Wetlands, watercourses or Karakambati RF – NW – 8.3 Km other water bodies, coastal zone, biospheres, Swarnamukhi River – North – 0.7 Km. mountains, forests 3 Areas used by protected, important or sensitive NA species of flora or fauna for breeding, nesting, foraging, resting, over wintering, migration 4 Inland, coastal, marine or underground waters NO 5 State, National boundaries NO 6 Route s or facilities used by the public for access NO to recreation or other tourist, pilgrim areas 7 Defense installations NO 8 Densely popul ated or buil t-up a rea YES Adusupalem is at a distance of 0.38 km in North direction. 9 Areas occupied by sensitive man -made land uses NA (hospitals, schools, places of worship, community facilities) 10 Areas containing important, high quality or sca rce NO resources (ground water resources, surface resources, forestry, agriculture, fisheries, tourism, minerals) 11 Areas alrea dy subjected to pollution or NO environmental damage. (those where existing legal environmental standard s are exceeded) 12 Ar eas sus ceptible to natural h azard which could NO cause the project to present environmental problems ( earthquakes, subsidence, landslides, erosion, flooding or extreme or adverse climatic conditions )

Form I Page 10

Radiant Pharma

(IV) Proposed Terms of Reference for EIA studies Scope of Work of EIA

The standard terms of reference (page 181-187) issued by the Ministry of Environment Forest and Climate change shall be followed for preparation of EIA report. Any additional study proposed by the SEAC shall also be completed.

Ref: Standard Terms of Reference (TOR) for EIA/EMPO report for projects/activities requiring environmental clearance under EIA notification, 2006, MoEFCC, GOI, and April 2015.

I hereby give the undertaking that data and information given in the application and enclosures are true to the best of my knowledge and belief and I am aware that if any part of the data and information submitted is found to be false or misleading at any stage, the project will be rejected and clearance given, if any to the project will be revoked at our risk and cost.

Date:

Place:

Signature of the applicant With Name and Full Address (Project Proponent/Authorized Signatory)

C. Shankar Giri Babu (Managing Partner) Radiant Pharma, Door No. 19-3-29/D1, Kennedy Nagar, Tiruchanoor Road, Tirupati, Chittoor, Andhra Pradesh – 517 502

Form I Page 11

RADIANT PHARMA SY. NO. 62A, GAJULAMANDYAM IDA, RENIGUNTA MANDAL, CHITTOR DISTRICT, ANDHRA PRADESH

ANNEXURES

Project No. 0519-16-01 May 2019

SUBMITTED TO STATE LEVEL ENVIRONMENT IMPACT ASSESSMENT AUTHORITY, ANDHRA PRADESH, GOVERNMENT OF INDIA Radiant Pharma Form I Annexure

Location Map of Radiant Pharma

Page 1

Radiant Pharma Form I Annexure

B P

P L

A O C

H B R

T C

A E

O C

H I

4 . 5

m W D I E

R O

A D

T K

T r

e y e

t Pharma t

r D

dian

. O

R K

W n

A R

I .

A U G

T A

I O A

C D

4 . 5

m W D I E

R O A D

O Plant LayoutPlant

y r

a n

D e

r g

. t

m t

m f

e e

r q

9 3

- .

8 .

d . 6

0 3 .

3 6

4 4 a S

2 4 . 2 2

t n

e e

q S

. 8

4 7

1 3 c

S 3

E O

S R

E T A G

D A R O

B . T . R O A D

D A R O

Page 2

Radiant Pharma Form I Annexure

ANNEXURE - I

M/s. Radiant Pharma proposes to set up Synthetic Organic Chemicals (Bulk Drugs & Intermediates) unit in an area of 1.55 acres of land on lease from Sapthagiri Industries for a period of 7 years at Sy. No. 62A, Gajulamandyam IDA, Renigunta Mandal, Chittoor District, Andhra Pradesh. The proposed list products and manufacturing capacity is presented in Table A-1 respectively. Table A-1 Manufacturing Capacity S. No Name of Product C A S No. Capacity (Kg/day) 1 S (2) Amino Butramide HCl 7682-20-4 1000 2 Diethyl Dipropylmalonate 6065-63-0 1000 3 Zolmitriptan 139264-17-8 50 4 Empagliflozin 864070-44-0 200 Total – Worst Case any 2 Products on Campaign Basis 2000

Page 3

Radiant Pharma Form I Annexure

Process Description of Diethyl Dipropylmalonate Reaction Scheme

Process Description: Diethyl Malonate reacts with N-Propyl Bromide in presence of sodium hydroxide to give Diethyl Dipropylmalonate. The process flow diagram for Diethyl Dipropylmalonate is presented in Fig A-1 and material balance is presented in Table A-2.

Fig A-1 Process Flow Diagram of Diethyl Dipropylmalonate

Table A-2 Material Balance for Diethyl Dipropylmalonate Input Quantity Output Quantity Remarks (Kg/day) (Kg/day) Diethylmalonate 724.4 Diethyl Dipropylmalonate 1000 Final Product N Propyl Bromide 1113 Sodium Bromide 843.1 To Waste Water Sodium Hydroxide 354.6 Diethylmalonate 68.8 Organic Residue Water 7500 N Propyl Bromide 105.7 To Waste Water Hydrochloric Acid 24.8 Sodium Chloride 39.5 To Waste Water Water 7659.6 To Waste Water Total Input 9716.7 Total Output 9716.7

Page 4

Radiant Pharma Form I Annexure

ANNEXURE – II: Wastewater Treatment Facilities The effluent generated mainly from process, washings, and scrubbers, cooling towers & boiler blow downs and domestic effluent. Effluent from Process, Washings, Scrubber, Boiler, Cooling tower and RO Rejects is sent to Effluent Treatment System and treated effluent is reused for cooling towers. Domestic effluent sent to septic tank followed by soak pit. Total Effluent generated and mode of treatment is presented in Table A-3.

Table A-3 Quantity of Effluent Generated and Mode of Treatment Description Quantity Mode of Treatment (KLD) HTDS Effluents Process 9.6 Sent to Stripper followed by MEE and ATFD. Washings 2 Stripper Condensate sent to Cement Plants for Co-Incineration. MEE and ATFD Condensate sent to Biological treatment plant followed by RO. RO rejects sent to MEE and permeate is reused in cooling towers make-up. Scrubber Effluent 5 Sent to MEE followed by AFTD, Biological DM rejects 1 treatment plant and RO. Total - I 17.6 LTDS Effluents Boiler Blow downs 3 Sent to Biological Treatment System followed Cooling Tower Blow downs 5 by RO. RO permeate reused for cooling tower makeup. RO rejects sent to MEE. Domestic Wastewater 1.8 Total - II 9.8 Grand Total (I+II) 27.4

Page 5

Radiant Pharma Form I Annexure

ANNEXURE – III: Water Balance

Water is required for process, scrubbers, washing, cooling tower makeup, steam generation and domestic purposes. The total water requirement shall be 58.4 KLD, out of which 33.4 KLD shall be fresh water and balance 25 KLD shall be recycled water. The required water shall be drawn from ground water/APIIC (Industrial supply) in addition to reuse of treated wastewater. The water balance is presented in Table A-4. Table A- 4 Total Water Balance (Tentative) Purpose INPUT(KLD) OUTPUT (KLD) Fresh Water Recycled Water Loss Effluent Process 8.4 9.6 Washings 2 2 Scrubber 5 5 Boiler Feed 6 4 7 3 Cooling Tower 7 21 23 5 DM Rejects 1 1 Domestic 2 0.2 1.8 Gardening 2 2 Gross Total 33.4 25 32.2 27.4 Total 58.4 59.6 * Process effluents contain soluble raw materials, byproducts, solvents etc.

Page 6

Radiant Pharma Form I Annexure

ANNEXURE – IV: Solid Waste

Solid wastes are generated from process, effluent treatment system, DG sets and boilers. The process residue and solvent residue are sent to cement plants for co-incineration. The evaporation salts are sent to TSDF. Waste oil and used batteries from the DG sets are sent to authorized recyclers. The sludge from effluent treatment plant is considered hazardous and the same is sent to TSDF. Ash from boiler is sold to brick manufacturers. The total solid waste generated and mode of disposal is presented in A-5.

Table A-5 Solid Waste Details (Tentative) S.No Description Units Quantity Mode of Disposal 1 Ash from Boiler TPD 4.56 Sold to Brick manufactures 2 Solvent Residue Kg/day 120 Sent to TSDF/Cement Industries 3 Process Organic Kg/day 372.3 residue 4 Process Inorganic Kg/day 50 Sent to TSDF Residue 8 Mixed Solvents Kg/day 259.4 Sent to authorized recovery units/ Cement plants for co-incineration. 9 Spent Solvent Kg/day 2334.2 Recovered within the plant premises. 10 Stripper distillate Kg/day 124.8 Sent to Cement Industries for Co- incineration. 11 Evaporation Salts TPD 1.75 Sent to TSDF 12 ETP Sludge Kg/day 17.5 Sent to TSDF 13 Detoxified containers No.s/year 700 Sent to Authorised agencies after detoxification 14 Waste oil Kl/Annum 0.41 Sent to Authorized Recyclers 15 Used batteries No.s/year 10 Sent to Authorized Recyclers

Page 7

Radiant Pharma Form I Annexure

ANNEXURE – V: Stack Emissions Details

The sources of air emission expected from the plant are gaseous emissions from proposed 2 TPH coal fired boilers with Multicone Separators as control equipment and DG set of 250 KVA proposed as standby during load shut down. DG sets shall be provided with stack height based on the CPCB formula for effective stack height. The emission rates of PM,

SO 2, NOx and PM from each stack are presented in Table A-6.

Table A-6 Stack Emission Details S.No Stack Attached to Stack Dia of Temp.of Exit Pollutant Emission Rate Height stack exhaust Velocity (g/sec) 0 (m) at top (m) gases ( C) (m/sec) PM SO 2 NOx 1 2 TPH Coal Fired 20 0.5 170 7 0.035 0.16 0.23 Boiler 2 *DG Set 250 KVA 3 0.4 150 8 0.03 0.11 0.15 *DG sets will be used during load shut down by APTRANSCO.

Page 8

RADIANT PHARMA SY. NO. 62A, GAJULAMANDYAM IDA, RENIGUNTA MANDAL, CHITTOR DISTRICT, ANDHRA PRADESH

STUDIES AND DOCUMENTATION BY TEAM Labs and Consultants QCI: MoE&F OM, List A-1, S.No.25. (An ISO 9001:2008, ISO 14001:2004 & OHSAS 18001:2007 Certified Organization) B-115, Annapurna Block, Aditya Enclave Ameerpet, Hyderabad-500 038. Phone: 040-23748 555/616, Telefax: 040-23748666 Email: [email protected]